* indicates Bates student
Kelsey, J. E., *Beer, T., *Lee, E., & *Wagner, A. (2002). Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats. Psychopharmacology, 161, 370-378.
Kelsey, J. E., *Mague, S. D., *Pijanowski, R. S., *Harris, R. C., Kleckner, N. W., & *Matthews, R. T. (2004). NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats. Psychopharmacology, 175, 179-188.
Kelsey, J. E., & *Calabro, S. (2008) Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats. Psychopharmacology, 198, 461-466.
Kelsey, J. E., *Langelier, N.A., *Oriel, B. S., & *Reedy, C. (2009). The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. Psychopharmacology, 201, 529-539.
Kelsey, J. E., *Gerety, L. P., & *Guerriero, R. M. (2009). Electrolytic lesions of the nucleus accumbens core (but not the medial shell) and the basolateral amygdala enhance context specific locomotor sensitization to nicotine in rats. Behavioral Neuroscience, 123, 577-588.
Kelsey, J. E., *Harris, O., & *Cassin, J. J. (2009). The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson’s disease. Behavioural Brain Research, 203, 304-307.